The University of Michigan released a discussion between the press staff and Dr. Oliver discussing the blood brain barrier on a chip device developed with Professors Merajver and Takayama. The potential of this platform may aid in precision phenotyping of cancer cells both prior and after diagnosis of brain metastasis enabling tailoring of the therapeutics and treatment given to a patient.
